MYC and lung carcinoma: Lastly, given the similar involvement of MYC in the response to combined Sotorasib and Midostaurin and, more importantly, that MYC amplification has been reported in lung cancer tumors acquiring resistance to Sotorasib50, we tested MYC function in the context of KRASG12Ci treatment.